Can Annovis Bio Deliver a Breakthrough in Alzheimer’s Disease?
Annovis Bio, Inc. (NYSE: ANVS) is a clinical-stage biotechnology Company that is developing a pipeline of drugs that target the treatment of Alzheimer’s and other neurodegenerative diseases through improvement of Axonal Transport. The Company is working on therapeutics for Alzheimer’s disease (AD), Parkinson’s disease (PD),...
